Publications by authors named "Yuhua Tao"
Second primary malignancy post immunotherapy: A case report of 2 cases.
Medicine (Baltimore)
March 2024
Article Synopsis
- Immune checkpoint inhibitors are effective first-line treatments for advanced cancers, but their impact on second primary tumors is not well understood.
- Two case reports highlight a 57-year-old woman and a 69-year-old man who developed second primary malignancies while receiving immunotherapy for lung and kidney cancers, respectively.
- Both patients experienced overall survival of over 12 months with manageable side effects, emphasizing the need for further research on immunotherapy adjustments and the importance of regular follow-ups for patients undergoing treatment.
(-)-Guaiol is a sesquiterpenoid found in many traditional Chinese medicines with potent antitumor activity. However, its therapeutic effect and mechanism in non-small cell lung cancer (NSCLC) have not been fully elucidated. In this study, (-)-Guaiol was found to induce immunogenic cell death (ICD) in NSCLC in vitro.
View Article and Find Full Text PDFCurcumin has a vital role in the development of renal carcinoma. Nevertheless, the mechanism of curcumin in renal carcinoma tumorigenesis remains largely unknown. Thirty renal carcinoma patients were recruited.
View Article and Find Full Text PDF[The visual outcome and related factors in cataract patients with extreme myopia].
Zhonghua Yan Ke Za Zhi
September 2003
Objective: A prospective study was performed to analyze the visual outcome and factors related to the visual outcome in cataract patients with extreme myopia, in order to provide a principle for intraocular lens (IOL) diopter chosen.
Methods: 43 cases were included in the present series (myopia over 10.00 D, axial length over 27.